Drugs / Toripalimub
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04284202 | Mar → Dec 2020 | non-small cell lung carcinoma | The Affiliated Hospital of Qingdao University | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Toripalimub | “Toripalimub 240mg injection day1” NCT04284202 ↗ |